Quantitation of PET signal as an adjunct to visual interpretation of florbetapir imaging
Open Access
- 7 January 2017
- journal article
- research article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 44 (5) , 825-837
Abstract
This study examined the feasibility of using quantitation to augment interpretation of florbetapir PET amyloid imaging.Keywords
This publication has 26 references indexed in Scilit:
- Appropriate Use Criteria for Amyloid PET: A Report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer’s AssociationJournal of Nuclear Medicine, 2013
- Potential Impact of Amyloid Imaging on Diagnosis and Intended Management in Patients With Progressive Cognitive DeclineAlzheimer Disease & Associated Disorders, 2013
- Performance Characteristics of Amyloid PET with Florbetapir F 18 in Patients with Alzheimer's Disease and Cognitively Normal SubjectsJournal of Nuclear Medicine, 2012
- Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environmentEuropean Journal of Nuclear Medicine and Molecular Imaging, 2012
- In Vivo Imaging of Amyloid Deposition in Alzheimer Disease Using the Radioligand 18F-AV-45 (Flobetapir F 18)Journal of Nuclear Medicine, 2010
- Phase 1 Study of the Pittsburgh Compound B Derivative 18F-Flutemetamol in Healthy Volunteers and Patients with Probable Alzheimer DiseaseJournal of Nuclear Medicine, 2009
- FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's diseaseBrain, 2007
- Early 18F-FDG PET for Prediction of Prognosis in Patients with Diffuse Large B-Cell Lymphoma: SUV-Based Assessment Versus Visual AnalysisJournal of Nuclear Medicine, 2007
- Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyondStatistics in Medicine, 2007
- Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐BAnnals of Neurology, 2004